INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 246 filers reported holding INARI MED INC in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,575,602 | -5.8% | 44,300 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,735,082 | -40.3% | 44,300 | -38.6% | 0.00% | 0.0% |
| Q4 2022 | $4,582,612 | -97.8% | 72,099 | -97.5% | 0.00% | -98.4% |
| Q3 2022 | $212,404,000 | +7.0% | 2,924,062 | +0.2% | 0.06% | +14.8% |
| Q2 2022 | $198,467,000 | -22.8% | 2,919,064 | +2.9% | 0.05% | -8.5% |
| Q1 2022 | $257,240,000 | +0.1% | 2,838,045 | +0.8% | 0.06% | +9.3% |
| Q4 2021 | $257,006,000 | +27.9% | 2,815,886 | +13.7% | 0.05% | +17.4% |
| Q3 2021 | $200,880,000 | +320.6% | 2,476,938 | +383.7% | 0.05% | +318.2% |
| Q2 2021 | $47,764,000 | -0.8% | 512,050 | +13.8% | 0.01% | -8.3% |
| Q1 2021 | $48,150,000 | +22.6% | 450,000 | 0.0% | 0.01% | +9.1% |
| Q4 2020 | $39,281,000 | +26.5% | 450,000 | 0.0% | 0.01% | +10.0% |
| Q3 2020 | $31,059,000 | +42.5% | 450,000 | 0.0% | 0.01% | +42.9% |
| Q2 2020 | $21,798,000 | – | 450,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,426,584 | $115,696,000 | 3.81% |
| Affinity Asset Advisors, LLC | 135,000 | $10,949,000 | 2.76% |
| SECTORAL ASSET MANAGEMENT INC | 289,650 | $23,491,000 | 1.95% |
| Pier Capital, LLC | 99,434 | $8,064,000 | 0.84% |
| Beck Bode, LLC | 27,853 | $2,259,000 | 0.63% |
| CNA FINANCIAL CORP | 22,993 | $1,865,000 | 0.51% |
| NEXT CENTURY GROWTH INVESTORS LLC | 59,245 | $4,804,000 | 0.42% |
| Birchview Capital, LP | 7,000 | $568,000 | 0.39% |
| PDT Partners, LLC | 59,849 | $4,854,000 | 0.35% |
| HAMILTON LANE ADVISORS LLC | 24,900 | $2,019,000 | 0.34% |